Hematopoietic stromal cells and megakaryocyte development

Hematology

Volumn 16, Issue 2, 2011, Pages 67-72

  Feng, Yimei ^a   Gao, Lei ^a   Chen, Xinghua ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cytokines; Hematopoietic microenvironment; Megakaryocytopoiesis; Stromal cells

Indexed keywords

CD31 ANTIGEN; CELL ADHESION MOLECULE; CYTOKINE; FAS LIGAND; FIBROBLAST GROWTH FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 3; INTERLEUKIN 6; INTERLEUKIN 7; PLATELET DERIVED GROWTH FACTOR; SCLEROPROTEIN; STEM CELL FACTOR; STROMAL CELL DERIVED FACTOR 1; THROMBOPOIETIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOG 1; TRANSCRIPTION FACTOR GATA 1; TRANSCRIPTION FACTOR NF E2; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VERY LATE ACTIVATION ANTIGEN 4; VERY LATE ACTIVATION ANTIGEN 5;

BONE MARROW DERIVED STROMA CELL; CELL DIFFERENTIATION; CELL INTERACTION; CELL MATURATION; CELL THERAPY; GENE THERAPY; HEMATOPOIETIC STROMA CELL; HEMATOPOIETIC SYSTEM; HUMAN; IMMUNOMODULATION; MEGAKARYOCYTE; MEGAKARYOPOIESIS; MICROENVIRONMENT; PARACRINE SIGNALING; PRIORITY JOURNAL; SHORT SURVEY; TISSUE REPAIR; UMBILICAL CORD BLOOD DERIVED STROMA CELL;

BONE MARROW CELLS; CELL ADHESION MOLECULES; CYTOKINES; FETAL BLOOD; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC SYSTEM; HUMANS; PLATELET TRANSFUSION; STROMAL CELLS; THROMBOPOIESIS;

EID: 79952653707     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1179/102453311X12940641877920     Document Type: Short Survey

References (92)

1. First LR, Smith BR, Lipton J, Nathan DG, Parkman R, Rappeport JM. Isolated thrombocytopenia after allogeneic bone marrow transplantation: existence of transient and chronic thrombocytopenic syndromes. Blood 1985;65:368-74. (Pubitemid 15163574)
2. Kessinger A, Armitage JO, Landmark JD, Smith DM, Weisenburger DD. Autologous peripheral hematopoietic stem cell transplantation restores hematopoietic function following marrow ablative therapy. Blood 1988:71:723-7.
3. Maurer AM, Liu Y, Caen JP, Han ZC. Ex vivo expansion of megakaryocytic cells. Int J Hematol 2000;71:203-10.
4. Gibson LF, Fortney J, Landreth KS, Piktel D, Ericson SG, Lynch JP. Disruption of bone marrow stromal cell function by etoposide. Biol Blood Marrow Transplant 1997;3:122-32. (Pubitemid 127530475)
5. Hiwase SD, Dyson PG, To LB, Lewis ID. Cotransplantation of placental mesenchymal stromal cells enhances single and double cord blood engraftment in nonobese diabetic/severe combined immune deficient mice. Stem Cells 2009;27:2293-300.
6. Dorshkind K. Regulation of hemopoiesis by bone marrow stromal cells and their products. Annu Rev Immunol 1990;8:111-37. (Pubitemid 20135623)
7. Angelopoulou M, Novelli E, Grove JE, Rinder HM, Civin C, Cheng L, et al. Cotransplantation of human mesenchymal stem cells enhances human myelopoiesis and megakaryocytopoiesis in NOD/SCID mice. Exp Hematol 2003;31:413-20. (Pubitemid 36579367)
8. Erices AA, Allers CI, Conget PA, Rojas CV, Minguell JJ. Human cord blood-derived mesenchymal stem cells home and survive in the marrow of immunodeficient mice after systemic infusion. Cell Transplant 2003;12:555-61. (Pubitemid 37204412)
9. Gordge MP. Megakaryocyte apoptosis: sorting out the signals. Br J Pharmacol 2005;145:271-3. (Pubitemid 40896071)
10. Ayala F, Dewar R, Kieran M, Kalluri R. Contribution of bone microenvironment to leukemogenesis and leukemia progression. Leukemia 2009;23:2233-41.
11. Yin T, Li L. The stem cell niches in bone. J Clin Invest 2006;116:1195-201.
12. Islam A. Haemopoietic stem cell: a new concept. Leuk Res 1985;9:1415-32. (Pubitemid 16199184)
13. Huang S, Terstappen LW. Formation of haematopoietic microenvironment and haematopoietic stem cells from single human bone marrow stem cells. Nature 1992;360:745-9. (Pubitemid 23012272)
14. Singer JW, Keating A, Cuttner J, Gown AM, Jacobson R, Killen PD, et al. Evidence for a stem cell common to hematopoiesis and its in vitro microenvironment: studies of patients with clonal hematopoietic neoplasia. Leuk Res 1984;8:535-45. (Pubitemid 14051257)
15. Simmons PJ, Torok-Storb B. CD34 expression by stromal precursors in normal human adult bone marrow. Blood 1991;78:2848-53.
16. Waller EK, Olweus J, Lund-Johansen F, Huang S, Nguyen M, Guo GR, et al. The "common stem cell" hypothesis reevaluated: human fetal bone marrow contains separate populations of hematopoietic and stromal progenitors. Blood 1995;85:2422-35.
17. Simmons P, Gronthos S, Zannettino A. The development of stromal cells. In: Hematopoiesis: a developmental approach. New York: Oxford University Press; 2001. p. 718-26.
18. Short B, Brouard N, Occhiodoro-Scott T, Ramakrishnan A, Simmons PJ. Mesenchymal stem cells. Arch Med Res 2003;34:565-71. (Pubitemid 38084710)
19. Horwitz EM, Le Blanc K, Dominici M, Mueller I, Slaper-Cortenbach I, Marini FC, et al. Clarification of the nomenclature for MSC: the International Society for Cellular Therapy position statement. Cytotherapy 2005;7:393-5. (Pubitemid 41671625)
20. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006;8:315-7.
21. Majumdar MK, Thiede MA, Mosca JD, Moorman M, Gerson SL. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J Cell Physiol 1998;176:57-66. (Pubitemid 28277195)
22. Seshi B, Kumar S, Sellers D. Human bone marrow stromal cell: coexpression of markers specific for multiple mesenchymal cell lineages. Blood Cells Mol Dis 2000;26:234-46.
23. Dennis JE, Charbord P. Origin and differentiation of human and murine stroma. Stem Cells 2002;20:205-14. (Pubitemid 34507437)
24. Simmons PJ, Torok-Storb B. Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood 1991;78:55-62.
25. + murine B-cell progenitors and functions to regulate stromal cell-dependent lymphopoiesis. Blood 1992;80:2021-9.
26. Haynesworth SE, Baber MA, Caplan AI. Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies. Bone 1992;13:69-80.
27. Guerriero A, Worford L, Holland HK, Guo GR, Sheehan K, Waller EK. Thrombopoietin is synthesized by bone marrow stromal cells. Blood 1997;90:3444-55. (Pubitemid 27473414)
28. Rokhlin O, Cohen M, Kubagawa H, Letarte M, Cooper M. Differential expression of endoglin on fetal and adult hematopoietic cells in human bone marrow. J Immunol 1995;154:4456.
29. Simmons PJ, Masinovsky B, Longenecker BM, Berenson R, Torok-Storb B, Gallatin WM. Vascular cell adhesion molecule-1 expressed by bone marrow stromal cells mediates the binding of hematopoietic progenitor cells. Blood 1992;80:388-95.
30. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-7. (Pubitemid 29282067)
31. Tolar J, Hippen KL, Blazar BR. Immune regulatory cells in umbilical cord blood: T regulatory cells and mesenchymal stromal cells. Br J Haematol 2009;147:200-6.
32. Kohler T, Plettig R, Wetzstein W, Schaffer B, Ordemann R, Nagels HO, et al. Defining optimum conditions for the ex vivo expansion of human umbilical cord blood cells. Influences of progenitor enrichment, interference with feeder layers, early-acting cytokines and agitation of culture vessels. Stem Cells 1999;17:19-24.
33. Barker JN, Wagner JE. Umbilical cord blood transplantation: current practice and future innovations. Crit Rev Oncol Hematol 2003;48:35-43. (Pubitemid 37336490)
34. + cells in vitro. Blood Cells Mol Dis 2006;36:322-8.
35. Hao L, Zhang C, Chen XH, Zou ZM, Zhang X, Kong PY, et al. Human umbilical cord blood-derived stromal cells suppress xenogeneic immune cell response in vitro. Croat Med J 2009;50:351-60.
36. Oh W, Kim DS, Yang YS, Lee JK. Immunological properties of umbilical cord blood-derived mesenchymal stromal cells. Cell Immunol 2008;251:116-23.
37. Feng Y, Chen X, Gao L. Hypothesis: human umbilical cord blood-derived stromal cells promote megakaryocytopoiesis through the influence of SDF-1 and PECAM-1. Cell Biochem Biophys 2010;58:25-30.
38. Gao L, Chen XH, Feng YM, Zhang X, Yu SC, Zhang C, et al. Human umbilical cord blood-derived stromal cells: multifaceted regulators of megakaryocytopoiesis. Cell Cycle 2010;9:1342-53.
39. Schick PK, Wojenski CM, He X, Walker J, Marcinkiewicz C, Niewiarowski S. Integrins involved in the adhesion of megakaryocytes to fibronectin and fibrinogen. Blood 1998;92:2650-6. (Pubitemid 28469075)
40. Miyake K, Medina K, Ishihara K, Kimoto M, Auerbach R, Kincade PW. A VCAM-like adhesion molecule on murine bone marrow stromal cells mediates binding of lymphocyte precursors in culture. J Cell Biol 1991;114:557-65. (Pubitemid 21909823)
41. Juneja HS, Schmalsteig FC, Lee S, Chen J. Vascular cell adhesion molecule-1 and VLA-4 are obligatory adhesion proteins in the heterotypic adherence between human leukemia/lymphoma cells and marrow stromal cells. Exp Hematol 1993;21:444-50. (Pubitemid 24215316)
42. Cui L, Ramsfjell V, Borge OJ, Veiby OP, Lok S, Jacobsen SE. Thrombopoietin promotes adhesion of primitive human hemopoietic cells to fibronectin and vascular cell adhesion molecule-1: role of activation of very late antigen (VLA)-4 and VLA-5. J Immunol 1997;159:1961-9. (Pubitemid 127484186)
43. Avraham H, Banu N, Scadden DT, Abraham J, Groopman JE. Modulation of megakaryocytopoiesis by human basic fibroblast growth factor. Blood 1994;83:2126-32. (Pubitemid 24112723)
44. Avraham H, Cowley S, Chi SY, Jiang S, Groopman JE. Characterization of adhesive interactions between human endothelial cells and megakaryocytes. J Clin Invest 1993;91:2378-84. (Pubitemid 23182486)
45. Avraham H, Scadden DT, Chi S, Broudy VC, Zsebo KM, Groopman JE. Interaction of human bone marrow fibroblasts with megakaryocytes: role of the c-kit ligand. Blood 1992;80:1679-84.
46. Dhanjal TS, Pendaries C, Ross EA, Larson MK, Protty MB, Buckley CD, et al. A novel role for PECAM-1 in megakaryocytokinesis and recovery of platelet counts in thrombocytopenic mice. Blood 2007;109:4237-44. (Pubitemid 46743388)
47. Wu Y, Welte T, Michaud M, Madri JA. PECAM-1: a multifaceted regulator of megakaryocytopoiesis. Blood 2007;110:851-9. (Pubitemid 47267421)
48. Tanaka M, Aze Y, Fujita T. Adhesion molecule LFA-1/ICAM-1 influences on LPS-induced megakaryocytic emperipolesis in the rat bone marrow. Vet Pathol 1997;34:463-6. (Pubitemid 27391596)
49. Cobankara V, Oran B, Ozatli D, Haznedaroglu IC, Kosar A, Buyukasik Y, et al. Cytokines, endothelium, and adhesive molecules in pathologic thrombopoiesis. Clin Appl Thromb Hemost 2001;7:126-30. (Pubitemid 32242189)
50. Wickenhauser C, Schmitz B, Baldus SE, Henze F, Farahmand P, Frimpong S, et al. Selectins (CD62L, CD62P) and megakaryocytic glycoproteins (CD41a, CD42b) mediate megakaryocyte - fibroblast interactions in human bone marrow. Leuk Res 2000;24:1013-21.
51. Kaushansky K. Thrombopoietin. N Engl J Med 1998;339:746-54.
52. Yang M, Chesterman CN, Chong BH. Recombinant PDGF enhances megakaryocytopoiesis in vitro. Br J Haematol 1995;91:285-9.
53. Yang M, Li K, Chui CM, Yuen PM, Chan PK, Chuen CK, et al. Expression of interleukin (IL) 1 type I and type II receptors in megakaryocytic cells and enhancing effects of IL-1beta on megakaryocytopoiesis and NF-E2 expression. Br J Haematol 2000;111:371-80.
54. Yang M, Li K. The role of cytokines and transcription factors in megakaryocytopoiesis. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2002;10:580-5.
55. Perez LE, Alpdogan O, Shieh JH, Wong D, Merzouk A, Salari H, et al. Increased plasma levels of stromal-derived factor-1 (SDF-1/CXCL12) enhance human thrombopoiesis and mobilize human colony-forming cells (CFC) in NOD/SCID mice. Exp Hematol 2004;32:300-7. (Pubitemid 38328536)
56. Hodohara K, Fujii N, Yamamoto N, Kaushansky K. Stromal cell-derived factor-1 (SDF-1) acts together with thrombopoietin to enhance the development of megakaryocytic progenitor cells (CFU-MK). Blood 2000;95:769-75.
57. Kaushansky K. The molecular mechanisms that control thrombopoiesis. J Clin Invest 2005;115:3339-47. (Pubitemid 43121817)
58. Kaushansky K. Thrombopoietin and the hematopoietic stem cell. Ann NY Acad Sci 2005;1044:139-41. (Pubitemid 40967604)
59. Deutsch V, Tomer A. Megakaryocyte development and platelet production. Br J Haematol 2006;134:453-66. (Pubitemid 44141711)
60. Nagata Y, Nagahisa H, Nagasawa T, Todokoro K. Regulation of megakaryocytopoiesis by thrombopoietin and stromal cells. Leukemia 1997;11(Suppl. 3):435-8.
61. Nagahisa H, Nagata Y, Ohnuki T, Osada M, Nagasawa T, Abe T, et al. Bone marrow stromal cells produce thrombopoietin and stimulate megakaryocyte growth and maturation but suppress proplatelet formation. Blood 1996;87:1309-16. (Pubitemid 26056894)
62. Wang JF, Liu ZY, Groopman JE. The alpha-chemokine receptor CXCR4 is expressed on the megakaryocytic lineage from progenitor to platelets and modulates migration and adhesion. Blood 1998;92:756-64. (Pubitemid 28355456)
63. Avecilla ST, Hattori K, Heissig B, Tejada R, Liao F, Shido K, et al. Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis. Nat Med 2004;10:64-71. (Pubitemid 38524700)
64. Pang L, Weiss MJ, Poncz M. Megakaryocyte biology and related disorders. J Clin Invest 2005;115:3332-8. (Pubitemid 43121816)
65. Lane WJ, Dias S, Hattori K, Heissig B, Choy M, Rabbany SY, et al. Stromal-derived factor 1-induced megakaryocyte migration and platelet production is dependent on matrix metalloproteinases. Blood 2000;96:4152-9.
66. Gutierrez-Ramos JC, Olsson C, Palacios R. Interleukin (IL1 to IL7) gene expression in fetal liver and bone marrow stromal clones: cytokine-mediated positive and negative regulation. Exp Hematol 1992;20:986-90.
67. Su R, Li K, Yang M, Zhang X, Tsang K, Fok T, et al. Platelet-derived growth factor enhances ex vivo expansion of megakaryocytic progenitors from human cord blood. Bone Marrow Transplant 2001;27:1075.
68. + cells from human cord blood and enhances long-term culture-initiating cells, non-obese diabetic/severe combined immunodeficient repopulating cells and formation of adherent cells. Br J Haematol 2002;117:735-46.
69. Bruno E, Miller ME, Hoffman R. Interacting cytokines regulate in vitro human megakaryocytopoiesis. Blood 1989;73:671-7. (Pubitemid 19069167)
70. Fry T, Mackall C. The many faces of IL-7: from lymphopoiesis to peripheral T cell maintenance. J Immnol 2005;174:6571-6. (Pubitemid 40705615)
71. Gupta P, Blazar BR, Gupta K, Verfaillie CM. Human CD34+ bone marrow cells regulate stromal production of interleukin-6 and granulocyte colony-stimulating factor and increase the colony-stimulating activity of stroma. Blood 1998;91:3724-33. (Pubitemid 28225740)
72. Baatout S: Interleukin-6 and megakaryocytopoiesis: an update. Ann Hematol 1996;73:157-62.
73. Fujiki H, Kimura T, Minamiguchi H, Harada S, Wang JF, Nakao M, et al. Role of human interleukin-9 as a megakaryocyte potentiator in culture. Exp Hematol 2002;30:1373-80. (Pubitemid 35449793)
74. Teramura M, Kobayashi S, Hoshino S, Oshimi K, Mizoguchi H. Interleukin-11 enhances human megakaryocytopoiesis in vitro. Blood 1992;79:327.
75. Du X, Williams D. Interleukin-11: review of molecular, cell biology, and clinical use. Blood 1997;89:3897.
76. Avraham H, Vannier E, Cowley S, Jiang SX, Chi S, Dinarello CA, et al. Effects of the stem cell factor, c-kit ligand, on human megakaryocytic cells. Blood 1992;79:365-71.
77. Friel J, Itoh K, Bergholz U, Jucker M, Stocking C, Harrison P, et al. Hierarchy of stroma-derived factors in supporting growth of stroma-dependent hemopoietic cells: membrane-bound SCF is sufficient to confer stroma competence to epithelial cells. Growth Factors 2002;20:35-51. (Pubitemid 34693058)
78. Erickson-Miller CL, Ji H, Murphy MJ, Jr. Megakaryocytopoiesis and platelet production: does stem cell factor play a role? Stem Cells 1993;11(Suppl. 2):163-9.
79. Piacibello W, Garetto L, Sanavio F, Severino A, Fubini L, Stacchini A, et al. The effects of human FLT3 ligand on in vitro human megakaryocytopoiesis. Exp Hematol 1996;24:340-6. (Pubitemid 26093903)
80. Sigurjonsson OE, Gudmundsson KO, Haraldsdottir V, Rafnar T, Agnarsson BA, Gudmundsson S. Flt3/Flk-2 ligand in combination with thrombopoietin decreases apoptosis in megakaryocyte development. Stem Cells Dev 2004;13:183-91. (Pubitemid 38590921)
81. Sigurjonsson OE, Gudmundsson KO, Haraldsdottir V, Rafnar T, Gudmundsson S. Flt3/Flk-2-ligand in synergy with thrombopoietin delays megakaryocyte development and increases the numbers of megakaryocyte progenitor cells in serum-free cultures initiated with CD34+ cells. J Hematother Stem Cell Res 2002;11:389-400. (Pubitemid 34309532)
82. Allouche M, Bikfalvi A. The role of fibroblast growth factor-2 (FGF-2) in hematopoiesis. Prog Growth Factor Res 1995;6:35-48. (Pubitemid 2617292)
83. Quito F, Beh J, Bashayan O, Basilico C, Basch R. Effects of fibroblast growth factor-4 (k-FGF) on long-term cultures of human bone marrow cells. Blood 1996;87:1282.
84. Liu CH, Hwang SM. Cytokine interactions in mesenchymal stem cells from cord blood. Cytokine 2005;32:270-9.
85. Bikfalvi A, Han ZC, Fuhrmann G. Interaction of fibroblast growth factor (FGF) with megakaryocytopoiesis and demonstration of FGF receptor expression in megakaryocytes and megakaryocytic-like cells. Blood 1992;80:1905-13.
86. Shivdasani RA. Molecular and transcriptional regulation of megakaryocyte differentiation. Stem Cells 2001;19:397-407. (Pubitemid 32900082)
87. Gewirtz AM, Zhang J, Ratajczak J, Ratajczak M, Park KS, Li C, et al. Chemokine regulation of human megakaryocytopoiesis. Blood 1995;86:2559-67.
88. Scandura JM, Boccuni P, Massague J, Nimer SD. Transforming growth factor beta-induced cell cycle arrest of human hematopoietic cells requires p57KIP2 up-regulation. Proc Natl Acad Sci USA 2004;101:15231-6. (Pubitemid 39391747)
89. Verma A, Deb DK, Sassano A, Uddin S, Varga J, Wickrema A, et al. Activation of the p38 mitogen-activated protein kinase mediates the suppressive effects of type I interferons and transforming growth factor-beta on normal hematopoiesis. J Biol Chem 2002;277:7726-35. (Pubitemid 34968219)
90. Cheng L, Qasba P, Vanguri P, Thiede MA. Human mesenchymal stem cells support megakaryocyte and pro-platelet formation from CD34z hematopoietic progenitor cells. J Cell Physiol 2000;184:58-69. (Pubitemid 30349628)
91. Almeida-Porada G, Porada CD, Tran N, Zanjani ED. Cotransplantation of human stromal cell progenitors into preimmune fetal sheep results in early appearance of human donor cells in circulation and boosts cell levels in bone marrow at later time points after transplantation. Blood 2000;95:3620-7.
92. Chung NG, Jeong DC, Park SJ, Choi BO, Cho B, Kim HK, et al. Cotransplantation of marrow stromal cells may prevent lethal graft-versus-host disease in major histocompatibility complex mismatched murine hematopoietic stem cell transplantation. Int J Hematol 2004;80:370-6. (Pubitemid 39564640)